The estimated Net Worth of Jason D Aroesty is at least $5.1 Milion dollars as of 27 November 2020. Mr. Aroesty owns over 13,334 units of Heska stock worth over $1,599,947 and over the last 6 years he sold HSKA stock worth over $0. In addition, he makes $3,495,150 as Executive Vice President - International Diagnostics at Heska.
Sign up
Mr. Aroesty HSKA stock SEC Form 4 insiders trading
Jason has made over 1 trades of the Heska stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 13,334 units of HSKA stock worth $1,422,338 on 27 November 2020.
The largest trade he's ever made was exercising 13,334 units of Heska stock on 27 November 2020 worth over $1,422,338. On average, Jason trades about 6,667 units every 0 days since 2018. As of 27 November 2020 he still owns at least 13,334 units of Heska stock.
You can see the complete history of Mr. Aroesty stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jason Aroesty biography
Jason D. Aroesty serves as Executive Vice President - International Diagnostics of the Company. Mr. Aroesty worked more than 15 years in the In-Vitro Diagnostics industry, where he played key commercial leadership roles in the healthcare division at Siemens, a global imaging and laboratory diagnostics leader. Mr. Aroesty was based in Europe for more than 10 years, where he led multiple country organizations, eventually assuming European regional responsibilities. Prior to joining Heska, he was responsible for Global Sales, Marketing and Communications for Siemens Point of Care (2015-2018). Mr. Aroesty graduated with a BS degree from Syracuse University and an MBA degree from the University of Rochester's Simon School.
What is the salary of Jason Aroesty?
As the Executive Vice President - International Diagnostics of Heska, the total compensation of Jason Aroesty at Heska is $3,495,150. There are no executives at Heska getting paid more.
How old is Jason Aroesty?
Jason Aroesty is 45, he's been the Executive Vice President - International Diagnostics of Heska since 2018. There are 13 older and 2 younger executives at Heska. The oldest executive at Heska Corp. is Bonnie Trowbridge, 73, who is the Independent Director.
What's Jason Aroesty's mailing address?
Jason's mailing address filed with the SEC is Heska, 3760, Rocky Mountain Avenue, Loveland, Larimer County, Colorado, 80538, United States.
Insiders trading at Heska
Over the last 22 years, insiders at Heska have traded over $40,831,198 worth of Heska stock and bought 747,946 units worth $2,470,701 . The most active insiders traders include Jason A Napolitano, Robert B Grieve a Robert L Antin. On average, Heska executives and independent directors trade stock every 20 days with the average trade being worth of $1,041,873. The most recent stock trade was executed by Kevin S. Wilson on 6 January 2023, trading 11,018 units of HSKA stock currently worth $645,875.
What does Heska do?
heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a
What does Heska's logo look like?
Complete history of Mr. Aroesty stock trades at Heska
Heska executives and stock owners
Heska executives and other stock owners filed with the SEC include:
-
Jason Aroesty,
Executive Vice President - International Diagnostics -
Catherine Grassman,
Chief Financial Officer, Executive Vice President -
Kevin S. Wilson,
CEO, Pres & Director -
Kevin Wilson,
President, Chief Executive Officer, Director -
Catherine I. Grassman CPA,
Exec. VP & CFO -
Steven M. Eyl,
Exec. VP, Chief Commercial Officer & Pres of scil animal care company -
Dr. Nancy Wisnewski,
Exec. VP & COO -
Nancy Wisnewski,
Chief Operating Officer, Executive Vice President -
Steven Eyl,
Executive Vice President, Chief Commercial Officer, Heska and President, scil animal care -
Scott Humphrey,
Independent Chairman of the Board -
Bonnie Trowbridge,
Independent Director -
Sharon Larson,
Independent Director -
David Sveen,
Independent Director -
Mark Furlong,
Independent Director -
Robert Antin,
Director -
Jon Aagaard,
Director, Investor Relations -
Stephen Davis,
Director -
Christopher Sveen,
Executive Vice President, Chief Administrative Officer and General Counsel, Heska and President, Diamond Animal Health -
Anthony C. Providenti Jr.,
Exec. VP of Corp. Devel. -
Laurie E. Peterson,
VP of Heska Des Moines -
Daniel J. Pollack,
VP of Imaging Operations, Treasurer & Assistant Sec. -
Eleanor F. Baker,
Exec. VP, MD & COO of scil animal care company -
Jason D. Aroesty,
Exec. VP of Global Sales and Marketing -
Steve Asakowicz,
EVP, Comp. Animal Health Sales -
Carol Wrenn,
Director -
Rod Lippincott,
EVP, Comp. Animal Health Sales -
John Mc Mahon,
VP, Fin. Oper. & Controller -
Michael J Mc Ginley,
EVP, Global Operations -
G Irwin Gordon,
Director -
John R Flanders,
V.P., General Counsel -
Gerald L Snodgrass,
VP, Sales -
Coast Investors Ltd Pacific,
10% owner -
Joseph H Ritter,
VP, Marketing & Int'l Bus. -
Ventures Ii, L.P.Charter Ve...,
-
A Barr Dolan,
Director -
Carol Talkington Verser,
Exec.V.P. Intel Prop & Bus Dev -
Lynnor B Stevenson,
Director -
Life Sciences I Iv Llc Charter,
10% owner -
Elisabeth H Demarse,
Director -
Tina Susan Nova,
Director -
Ventures Ii, L.P. Charter,
10% owner -
Lyle A Hohnke,
Director -
Dan T Stinchcomb,
Exec. V.P., Research and Dev. -
Albert Jr Honsch,
Vice President, Sales -
Jason A Napolitano,
Chief Strategy Officer -
Robert B Grieve,
Chief Executive Officer -
William A Aylesworth,
Director -
Joseph Aperfine,
EVP, Sales and Marketing -
Master Fund, L.P.Cmc Master...,
-
Michael A Bent,
V.P.Actg. Officer & Controller -
Claudine Zachara,
-
Master Fund, L.P.Cmc Master...,
-
John F Sasen,
Director -
Peter Eio,
Director -
Louise L. Mc Cormick,
Director -
Joachim A. Hasenmaier,
-
Eleanor F. Baker,
EVP, Managing Dir. & COO, scil -
Anthony C. Jr. Providenti,
EVP, Corporate Development -
Sharon J. Maples,